MEDP
Overvalued by 5.7% based on the discounted cash flow analysis.
Market cap | $12.08 Billion |
---|---|
Enterprise Value | $11.67 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $9.82 |
Beta | 0.0 |
Outstanding Shares | 30,983,399 |
Avg 30 Day Volume | 250,852 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 38.67 |
---|---|
PEG | 94.83 |
Price to Sales | 6.28 |
Price to Book Ratio | 18.85 |
Enterprise Value to Revenue | 5.95 |
Enterprise Value to EBIT | 32.9 |
Enterprise Value to Net Income | 37 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data